55 related articles for article (PubMed ID: 19998643)
1. Disparities in antiretroviral prescribing for blacks and whites in the United States.
Oramasionwu CU; Skinner J; Ryan L; Frei CR
J Natl Med Assoc; 2009 Nov; 101(11):1140-4. PubMed ID: 19998643
[TBL] [Abstract][Full Text] [Related]
2. Differences in national antiretroviral prescribing patterns between black and white patients with HIV/AIDS, 1996-2006.
Oramasionwu CU; Brown CM; Lawson KA; Ryan L; Skinner J; Frei CR
South Med J; 2011 Dec; 104(12):794-800. PubMed ID: 22089356
[TBL] [Abstract][Full Text] [Related]
3. Black race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study.
Oramasionwu CU; Hunter JM; Skinner J; Ryan L; Lawson KA; Brown CM; Makos BR; Frei CR
BMC Infect Dis; 2009 Aug; 9():127. PubMed ID: 19671170
[TBL] [Abstract][Full Text] [Related]
4. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.
Gebo KA; Fleishman JA; Conviser R; Reilly ED; Korthuis PT; Moore RD; Hellinger J; Keiser P; Rubin HR; Crane L; Hellinger FJ; Mathews WC;
J Acquir Immune Defic Syndr; 2005 Jan; 38(1):96-103. PubMed ID: 15608532
[TBL] [Abstract][Full Text] [Related]
5. Racial, gender and geographic disparities of antiretroviral treatment among US Medicaid enrolees in 1998.
King WD; Minor P; Ramirez Kitchen C; Oré LE; Shoptaw S; Victorianne GD; Rust G
J Epidemiol Community Health; 2008 Sep; 62(9):798-803. PubMed ID: 18701730
[TBL] [Abstract][Full Text] [Related]
6. Effect of dysthymia on receipt of HAART by minority HIV-infected women.
Turner BJ; Fleishman JA
J Gen Intern Med; 2006 Dec; 21(12):1235-41. PubMed ID: 17105522
[TBL] [Abstract][Full Text] [Related]
7. Racial Disparities in Differentiated Thyroid Cancer: Have We Bridged the Gap?
Shah SA; Adam MA; Thomas SM; Scheri RP; Stang MT; Sosa JA; Roman SA
Thyroid; 2017 Jun; 27(6):762-772. PubMed ID: 28294040
[TBL] [Abstract][Full Text] [Related]
8. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.
Hall HI; Frazier EL; Rhodes P; Holtgrave DR; Furlow-Parmley C; Tang T; Gray KM; Cohen SM; Mermin J; Skarbinski J
JAMA Intern Med; 2013 Jul; 173(14):1337-44. PubMed ID: 23780395
[TBL] [Abstract][Full Text] [Related]
9. Evaluating HIV/AIDS disparities for blacks in the United States: a review of antiretroviral and mortality studies.
Oramasionwu CU; Brown CM; Lawson KA; Ryan L; Frei CR
J Natl Med Assoc; 2009 Dec; 101(12):1221-9. PubMed ID: 20070010
[TBL] [Abstract][Full Text] [Related]
10. Black-White mortality from HIV in the United States before and after introduction of highly active antiretroviral therapy in 1996.
Levine RS; Briggs NC; Kilbourne BS; King WD; Fry-Johnson Y; Baltrus PT; Husaini BA; Rust GS
Am J Public Health; 2007 Oct; 97(10):1884-92. PubMed ID: 17761583
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
Mildvan D; Creagh T; Leitz G;
Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689
[TBL] [Abstract][Full Text] [Related]
12. The inability to take medications openly at home: does it help explain gender disparities in HAART use?
Sayles JN; Wong MD; Cunningham WE
J Womens Health (Larchmt); 2006 Mar; 15(2):173-81. PubMed ID: 16536681
[TBL] [Abstract][Full Text] [Related]
13. Racial and Ethnic Disparities in Sustained Viral Suppression and Transmission Risk Potential Among Persons Receiving HIV Care - United States, 2014.
Crepaz N; Dong X; Wang X; Hernandez AL; Hall HI
MMWR Morb Mortal Wkly Rep; 2018 Feb; 67(4):113-118. PubMed ID: 29389918
[TBL] [Abstract][Full Text] [Related]
14. Association of medical insurance and other factors with receipt of antiretroviral therapy.
Keruly JC; Conviser R; Moore RD
Am J Public Health; 2002 May; 92(5):852-7. PubMed ID: 11988459
[TBL] [Abstract][Full Text] [Related]
15. Appropriateness of antiretroviral therapy in clients of an HIV/AIDS case management organization.
Holmes WC; Pace JL; Frank I
AIDS Care; 2007 Feb; 19(2):273-81. PubMed ID: 17364410
[TBL] [Abstract][Full Text] [Related]
16. The effect of race/ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type 1-infected patients.
Jensen-Fangel S; Pedersen L; Pedersen C; Larsen CS; Tauris P; Møller A; Sørensen HT; Obel N
Clin Infect Dis; 2002 Dec; 35(12):1541-8. PubMed ID: 12471575
[TBL] [Abstract][Full Text] [Related]
17. Access to highly active antiretroviral therapy (HAART) for women and children in the WHO European Region 2002-2006.
Stengaard AR; Lazarus JV; Donoghoe MC; Nielsen S; Matic S
AIDS Care; 2009 Jul; 21(7):893-902. PubMed ID: 20024746
[TBL] [Abstract][Full Text] [Related]
18. Physician specialization and antiretroviral therapy for HIV.
Landon BE; Wilson IB; Cohn SE; Fichtenbaum CJ; Wong MD; Wenger NS; Bozzette SA; Shapiro MF; Cleary PD
J Gen Intern Med; 2003 Apr; 18(4):233-41. PubMed ID: 12709089
[TBL] [Abstract][Full Text] [Related]
19. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
Golub ET; Benning L; Sharma A; Gandhi M; Cohen MH; Young M; Gange SJ
Clin Infect Dis; 2008 Jan; 46(2):305-12. PubMed ID: 18171267
[TBL] [Abstract][Full Text] [Related]
20. Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy.
Eisenman D; Bogart LM; Bird CE; Collins RL; Golinelli D; Fremont A; Beckman R; Cunningham W
AIDS Patient Care STDS; 2007 Jun; 21(6):390-9. PubMed ID: 17594248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
